Comments
Loading...

89bio Analyst Ratings

ETNBNASDAQ
Logo brought to you by Benzinga Data
$8.80
-0.16-1.77%
Pre-Market: 5:09 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$49.00
Lowest Price Target1
$11.00
Consensus Price Target1
$27.75

89bio Analyst Ratings and Price Targets | NASDAQ:ETNB | Benzinga

89bio Inc has a consensus price target of $27.75 based on the ratings of 14 analysts. The high is $49 issued by Raymond James on November 8, 2024. The low is $11 issued by Goldman Sachs on March 14, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Citigroup, and HC Wainwright & Co. on March 14, 2025, March 13, 2025, and February 28, 2025, respectively. With an average price target of $19 between Goldman Sachs, Citigroup, and HC Wainwright & Co., there's an implied 115.88% upside for 89bio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Nov 24
3
Jan
2
Feb
1
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Citigroup
HC Wainwright & Co.
UBS
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for 89bio

Buy NowGet Alert
03/14/2025Buy Now24.98%Goldman Sachs
Andrea Newkirk
→ $11Initiates → NeutralGet Alert
03/13/2025Buy Now184.05%Citigroup
Geoff Meacham64%
→ $25Initiates → BuyGet Alert
02/28/2025Buy Now138.6%HC Wainwright & Co.
Ed Arce62%
$29 → $21ReiteratesBuy → BuyGet Alert
02/04/2025Buy NowWolfe Research
Andy Chen40%
Initiates → OutperformGet Alert
01/31/2025Buy Now331.76%UBS
Eliana Merle46%
$25 → $38MaintainsBuyGet Alert
01/21/2025Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
01/02/2025Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
11/11/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
11/08/2024Buy Now456.74%Raymond James
Steven Seedhouse58%
$53 → $49MaintainsStrong BuyGet Alert
09/20/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy Now502.19%Raymond James
Steven Seedhouse58%
$50 → $53MaintainsStrong BuyGet Alert
08/06/2024Buy Now36.35%RBC Capital
Brian Abrahams52%
$13 → $12MaintainsSector PerformGet Alert
08/06/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
07/01/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
06/12/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
06/11/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
05/17/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
05/17/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$29 → $29ReiteratesBuy → BuyGet Alert
05/15/2024Buy Now274.95%Evercore ISI Group
Liisa Bayko71%
$37 → $33MaintainsOutperformGet Alert
05/10/2024Buy Now229.5%HC Wainwright & Co.
Ed Arce62%
$31 → $29MaintainsBuyGet Alert
04/22/2024Buy Now240.86%B of A Securities
Alexandria Hammond42%
→ $30Assumes → BuyGet Alert
04/05/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
03/27/2024Buy Now252.22%HC Wainwright & Co.
Ed Arce62%
$31 → $31MaintainsBuyGet Alert
03/13/2024Buy Now252.22%HC Wainwright & Co.
Ed Arce62%
$31 → $31MaintainsBuyGet Alert
03/07/2024Buy Now320.4%Evercore ISI Group
Liisa Bayko71%
$29 → $37MaintainsOutperformGet Alert
03/06/2024Buy Now320.4%Evercore ISI Group
Liisa Bayko71%
$29 → $37MaintainsOutperformGet Alert
03/05/2024Buy NowOppenheimer
Jay Olson62%
MaintainsPerformGet Alert
03/04/2024Buy Now229.5%Cantor Fitzgerald
Kristen Kluska71%
$29 → $29ReiteratesOverweight → OverweightGet Alert
03/01/2024Buy Now59.07%RBC Capital
Brian Abrahams52%
$15 → $14MaintainsSector PerformGet Alert
03/01/2024Buy Now252.22%HC Wainwright & Co.
Ed Arce62%
$32 → $31MaintainsBuyGet Alert
01/12/2024Buy Now70.43%RBC Capital
Brian Abrahams52%
→ $15DowngradeOutperform → Sector PerformGet Alert
12/20/2023Buy Now263.59%HC Wainwright & Co.
Ed Arce62%
$35 → $32MaintainsBuyGet Alert
12/05/2023Buy Now297.67%HC Wainwright & Co.
Ed Arce62%
$35 → $35ReiteratesBuy → BuyGet Alert
11/28/2023Buy Now297.67%HC Wainwright & Co.
Ed Arce62%
→ $35ReiteratesBuy → BuyGet Alert
11/09/2023Buy Now172.69%RBC Capital
Brian Abrahams52%
$27 → $24MaintainsOutperformGet Alert
10/12/2023Buy Now184.05%UBS
Eliana Merle46%
$36 → $25MaintainsBuyGet Alert
10/11/2023Buy Now206.78%RBC Capital
Brian Abrahams52%
$34 → $27MaintainsOutperformGet Alert
09/22/2023Buy Now286.31%RBC Capital
Brian Abrahams52%
→ $34ReiteratesOutperform → OutperformGet Alert
08/28/2023Buy Now309.04%UBS
Eliana Merle46%
→ $36Initiates → BuyGet Alert
08/10/2023Buy Now297.67%HC Wainwright & Co.
Ed Arce62%
→ $35ReiteratesBuy → BuyGet Alert
08/10/2023Buy Now343.12%Cantor Fitzgerald
Kristen Kluska71%
$41 → $39MaintainsOverweightGet Alert
08/10/2023Buy Now286.31%RBC Capital
Brian Abrahams52%
$33 → $34MaintainsOutperformGet Alert
07/03/2023Buy Now320.4%BTIG
Justin Zelin40%
$30 → $37MaintainsBuyGet Alert
06/13/2023Buy Now456.74%Evercore ISI Group
Liisa Bayko71%
→ $49Initiates → OutperformGet Alert
05/11/2023Buy Now240.86%Oppenheimer
Jay Olson62%
→ $30ReiteratesOutperform → OutperformGet Alert
05/08/2023Buy Now297.67%HC Wainwright & Co.
Ed Arce62%
$30 → $35MaintainsBuyGet Alert
05/05/2023Buy Now365.85%Cantor Fitzgerald
Kristen Kluska71%
$40 → $41MaintainsOverweightGet Alert
05/05/2023Buy Now274.95%RBC Capital
Brian Abrahams52%
$36 → $33MaintainsOutperformGet Alert
03/23/2023Buy Now468.1%Raymond James
Steven Seedhouse58%
$25 → $50MaintainsStrong BuyGet Alert
03/23/2023Buy Now240.86%HC Wainwright & Co.
Ed Arce62%
$25 → $30MaintainsBuyGet Alert
03/22/2023Buy Now309.04%RBC Capital
Brian Abrahams52%
$27 → $36MaintainsOutperformGet Alert
03/22/2023Buy Now468.1%Raymond James
Steven Seedhouse58%
$25 → $50MaintainsStrong BuyGet Alert
03/22/2023Buy Now411.29%Cantor Fitzgerald
Kristen Kluska71%
$34 → $45MaintainsOverweightGet Alert
03/20/2023Buy Now184.05%HC Wainwright & Co.
Ed Arce62%
$27 → $25MaintainsBuyGet Alert
03/14/2023Buy Now206.78%RBC Capital
Brian Abrahams52%
→ $27Reiterates → OutperformGet Alert
03/06/2023Buy Now286.31%Cantor Fitzgerald
Kristen Kluska71%
→ $34Reiterates → OverweightGet Alert
02/21/2023Buy Now104.52%Oppenheimer
Jay Olson62%
$12 → $18MaintainsOutperformGet Alert
02/07/2023Buy Now206.78%HC Wainwright & Co.
Ed Arce62%
→ $27Reiterates → BuyGet Alert
11/11/2022Buy Now229.5%RBC Capital
Brian Abrahams52%
$35 → $29MaintainsOutperformGet Alert
09/14/2022Buy Now184.05%Raymond James
Steven Seedhouse58%
$14 → $25MaintainsStrong BuyGet Alert
08/17/2022Buy Now206.78%HC Wainwright & Co.
Ed Arce62%
$26 → $27MaintainsBuyGet Alert
07/28/2022Buy Now195.41%HC Wainwright & Co.
Ed Arce62%
$29 → $26MaintainsBuyGet Alert
07/11/2022Buy Now229.5%SVB Leerink
Thomas Smith33%
$50 → $29MaintainsOutperformGet Alert
06/30/2022Buy Now70.43%Oppenheimer
Jay Olson62%
$40 → $15MaintainsOutperformGet Alert
06/30/2022Buy Now59.07%Raymond James
Steven Seedhouse58%
$12 → $14MaintainsStrong BuyGet Alert
06/29/2022Buy Now172.69%BTIG
Justin Zelin40%
$28 → $24MaintainsBuyGet Alert
05/18/2022Buy Now115.88%Piper Sandler
Yasmeen Rahimi60%
$54 → $19MaintainsOverweightGet Alert
05/13/2022Buy Now354.48%Oppenheimer
Jay Olson62%
$49 → $40MaintainsOutperformGet Alert
05/12/2022Buy Now263.59%RBC Capital
Brian Abrahams52%
$35 → $32MaintainsOutperformGet Alert
05/12/2022Buy Now36.35%Raymond James
Steven Seedhouse58%
$33 → $12UpgradeOutperform → Strong BuyGet Alert

FAQ

Q

What is the target price for 89bio (ETNB) stock?

A

The latest price target for 89bio (NASDAQ:ETNB) was reported by Goldman Sachs on March 14, 2025. The analyst firm set a price target for $11.00 expecting ETNB to rise to within 12 months (a possible 24.98% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for 89bio (ETNB)?

A

The latest analyst rating for 89bio (NASDAQ:ETNB) was provided by Goldman Sachs, and 89bio initiated their neutral rating.

Q

When was the last upgrade for 89bio (ETNB)?

A

The last upgrade for 89bio Inc happened on May 12, 2022 when Raymond James raised their price target to $12. Raymond James previously had an outperform for 89bio Inc.

Q

When was the last downgrade for 89bio (ETNB)?

A

The last downgrade for 89bio Inc happened on January 12, 2024 when RBC Capital changed their price target from N/A to $15 for 89bio Inc.

Q

When is the next analyst rating going to be posted or updated for 89bio (ETNB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 89bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 89bio was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.

Q

Is the Analyst Rating 89bio (ETNB) correct?

A

While ratings are subjective and will change, the latest 89bio (ETNB) rating was a initiated with a price target of $0.00 to $11.00. The current price 89bio (ETNB) is trading at is $8.80, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch